Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Parathyroid Carcinoma in Patients that Have Undergone Surgery for Primary Hyperparathyroidism

P. Libánský, S. Adámek, P. Broulík, M. Fialová, J. Kubinyi, R. Lischke, O. Naňka, P. Pafko, J. Šedý, V. Bobek,

. 2017 ; 31 (5) : 925-930.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024674

BACKGROUND/AIM: Parathyroid carcinoma is a rare clinical entity, which represents one of the main reasons, why surgery should be performed in specialized centres. Preoperatively, it is very difficult to distinguish between benign and malignant hyperparathyroidism. PATIENTS AND METHODS: During the years 1996-2016, we performed 2,220 operations in 2,075 patients with a diagnosis of primary hyperparathyroidism. RESULTS: Among these 2,220 operations, there were 16 operations for parathyroid carcinoma. These 16 operations, including reoperations, were performed in four patients. Two patients had no reoperation, but another 2 patients required 14 reoperations in total. Parathyroid carcinoma was described in 0.2% of all patients with a diagnosis of primary hyperparathyroidism. The number of operations was 0.73% of all operations of primary hyperparathyroidism in years 1996-2016. CONCLUSION: Prognosis of parathyroid carcinoma is quite favourable, patients evidence a long-term survival rate after the primary operation. However, every reoperation increases the number of possible complications, including recurrent laryngeal nerve injury.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024674
003      
CZ-PrNML
005      
20180716121235.0
007      
ta
008      
180709s2017 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/invivo.11148 $2 doi
035    __
$a (PubMed)28882960
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Libánský, Petr $u Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
245    10
$a Parathyroid Carcinoma in Patients that Have Undergone Surgery for Primary Hyperparathyroidism / $c P. Libánský, S. Adámek, P. Broulík, M. Fialová, J. Kubinyi, R. Lischke, O. Naňka, P. Pafko, J. Šedý, V. Bobek,
520    9_
$a BACKGROUND/AIM: Parathyroid carcinoma is a rare clinical entity, which represents one of the main reasons, why surgery should be performed in specialized centres. Preoperatively, it is very difficult to distinguish between benign and malignant hyperparathyroidism. PATIENTS AND METHODS: During the years 1996-2016, we performed 2,220 operations in 2,075 patients with a diagnosis of primary hyperparathyroidism. RESULTS: Among these 2,220 operations, there were 16 operations for parathyroid carcinoma. These 16 operations, including reoperations, were performed in four patients. Two patients had no reoperation, but another 2 patients required 14 reoperations in total. Parathyroid carcinoma was described in 0.2% of all patients with a diagnosis of primary hyperparathyroidism. The number of operations was 0.73% of all operations of primary hyperparathyroidism in years 1996-2016. CONCLUSION: Prognosis of parathyroid carcinoma is quite favourable, patients evidence a long-term survival rate after the primary operation. However, every reoperation increases the number of possible complications, including recurrent laryngeal nerve injury.
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $7 D015415
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a primární hyperparatyreóza $x diagnóza $x epidemiologie $x etiologie $x chirurgie $7 D049950
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multimodální zobrazování $7 D064847
650    _2
$a nádory příštítného tělíska $x komplikace $x diagnóza $x epidemiologie $x chirurgie $7 D010282
650    _2
$a paratyreoidektomie $7 D016105
650    _2
$a pooperační komplikace $7 D011183
650    _2
$a určení symptomu $7 D063189
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Adámek, Svatopluk $u Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Broulík, Petr $u Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Fialová, Martina $u Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Kubinyi, Josef $u Institute of Nuclear Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Lischke, Robert $u Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Naňka, Ondřej $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Pafko, Pavel $u Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Šedý, Jiří $u Department of Anatomy, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Bobek, Vladimír $u Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic vbobek@centrum.cz. Department of Laboratory Genetics, University Hospital Kralovske Vinohrady, Prague, Czech Republic. Department of Thoracic Surgery, Masaryk's Hospital in Usti nad Labem, Labem, Czech Republic. Department of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland.
773    0_
$w MED00175831 $t In vivo (Athens, Greece) $x 1791-7549 $g Roč. 31, č. 5 (2017), s. 925-930
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28882960 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180716121533 $b ABA008
999    __
$a ok $b bmc $g 1316805 $s 1021595
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 31 $c 5 $d 925-930 $i 1791-7549 $m In Vivo $n In Vivo $x MED00175831
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace